Humacyte Inc.

NASDAQ: HUMAW · Real-Time Price · USD
0.49
-0.03 (-5.50%)
At close: Aug 01, 2025, 3:43 PM

Humacyte Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
517K 7.23M n/a n/a n/a 10.79M n/a n/a n/a n/a 31K 1.3M 233K 177K 241K 690K 155K
Cost of Revenue
n/a 3.61M n/a 1.82M 1.79M 3.38M 1.31M 2M 2.08M 2.13M 2.05M 14.65M 2.05M 49K 49K 243.67K 15.14M
Gross Profit
n/a 3.61M n/a -1.82M -1.79M 7.41M -1.31M -2M -2.08M -2.13M -2.02M -13.35M -1.82M 128K 192K 446.33K -14.98M
Operating Income
-23.18M -28.09M -30.23M -29.5M -26.58M -26.18M -24.62M -26.73M -22.51M -20.79M -23.49M -18.53M -21.76M -21.63M -20.54M -19.27M -19.77M
Interest Income
662K 852K 911K 1.31M 1.03M 1.14M 1.37M 1.48M 1.48M 1.41M 883K 301K 31K 10K 3K 2K 1K
Pretax Income
39.14M -20.94M -39.2M -56.66M -31.9M -25.11M -26M -22.71M -36.97M -3.72M -25.28M 36.87M -19.83M 42.59M -31.56M -17.2M -20.3M
Net Income
39.14M -20.94M -39.2M -56.66M -31.9M -25.11M -26M -22.71M -61.84M 13.57M -25.43M 36.87M -16.47M 42.59M -31.56M -17.2M -20.3M
Selling & General & Admin
8.14M 11.05M 7.31M 3.92M 3.52M 2.62M 6.07M 3.08M 5.23M 5.83M 6.19M 5.18M 5.68M 5.55M 5.4M 5.39M 4.79M
Research & Development
15.42M 20.66M 22.93M 23.75M 21.26M 20.18M 18.55M 20.54M 17.28M 14.96M 17.34M 14.65M 16.31M 16.25M 15.39M 14.57M 15.14M
Other Expenses
147K n/a n/a n/a n/a n/a n/a n/a -266K -48K -31K n/a -233K n/a -1.25M n/a -155K
Operating Expenses
23.7M 31.7M 30.23M 27.68M 24.79M 22.8M 24.62M 23.62M 22.51M 20.79M 23.49M 18.53M 21.76M 21.63M 20.54M 19.27M 19.77M
Interest Expense
3M 2.51M 2.44M 2.52M 1.82M 1.73M 1.46M 1.71M 1.7M 1.64M 1.64M 1.49M 1.43M 1.4M 1.2M 1.22M 533K
Selling & Marketing Expenses
n/a 3.61M n/a -1.82M -1.79M -3.38M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
n/a 35.32M 30.23M 29.5M 26.58M 26.18M 24.62M 23.62M 22.51M 20.79M 23.49M 18.53M 21.76M 21.63M 20.54M 19.27M 19.77M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a 24.88M -17.3M 146K n/a -3.36M n/a n/a n/a 1K
Shares Outstanding (Basic)
131.5M 118.48M 119.41M 119.17M 108.25M 103.61M 103.44M 103.36M 103.26M 103.16M 103.03M 103.01M 103M 103M 43.95M 103M 103M
Shares Outstanding (Diluted)
131.76M 118.48M 119.41M 119.17M 108.25M 103.61M 103.44M 103.36M 103.26M 103.16M 103.03M 103.91M 103M 104.74M 43.95M 103M 103M
EPS (Basic)
0.28 1.08 -0.33 -0.48 -0.29 -0.24 -0.25 -0.22 -0.6 0.13 -0.25 0.36 -0.16 0.41 -0.72 -0.17 -0.2
EPS (Diluted)
0.28 1.08 -0.33 -0.48 -0.29 -0.24 -0.25 -0.22 -0.6 0.13 -0.25 0.35 -0.16 0.41 -0.72 -0.17 -0.2
EBITDA
-23.18M -16.62M -30.23M -52.33M -28.29M -20M -23.22M -19M -33.19M -37.91M -21.59M 40.39M -16.35M 46.04M -28.86M -17.2M -17.7M
EBIT
n/a -18.43M -36.76M -54.15M -30.08M -23.38M -24.53M -21M -35.27M -2.08M -23.64M 38.36M -18.4M 43.98M -30.36M -19.27M -19.77M
Depreciation & Amortization
n/a 1.81M 1.81M 1.82M 1.79M 3.38M 1.31M 2M 2.08M 2.13M 2.05M 2.03M 2.05M 2.06M 1.5M 2.07M 2.07M